INOTEK PHARMACEUTICALS CORP's ticker is ITEK and the CUSIP is 45780V102. A total of 54 filers reported holding INOTEK PHARMACEUTICALS CORP in Q2 2017. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $183,000 | -6.2% | 102,964 | 0.0% | 0.00% | – |
| Q2 2017 | $195,000 | -27.2% | 102,964 | -23.3% | 0.00% | – |
| Q1 2017 | $268,000 | -66.4% | 134,329 | +2.7% | 0.00% | – |
| Q4 2016 | $797,000 | -32.7% | 130,819 | +4.7% | 0.00% | -100.0% |
| Q3 2016 | $1,184,000 | +54.2% | 124,962 | +21.0% | 0.00% | – |
| Q2 2016 | $768,000 | +26.5% | 103,301 | +25.9% | 0.00% | – |
| Q1 2016 | $607,000 | -34.7% | 82,072 | -0.1% | 0.00% | -100.0% |
| Q4 2015 | $930,000 | +25.0% | 82,126 | +3.7% | 0.00% | – |
| Q3 2015 | $744,000 | +413.1% | 79,197 | +167.5% | 0.00% | – |
| Q2 2015 | $145,000 | – | 29,609 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|